心脏杂志
心髒雜誌
심장잡지
CHINESE HEART JOURNAL
2006年
1期
23-27
,共5页
李树壮%臧益民%王波%韦耿泽%胡玉珍%秦向阳%裴建明%周京军
李樹壯%臧益民%王波%韋耿澤%鬍玉珍%秦嚮暘%裴建明%週京軍
리수장%장익민%왕파%위경택%호옥진%진향양%배건명%주경군
钠/钙交换体%代谢性抑制预处理%心肌保护%心室肌细胞
鈉/鈣交換體%代謝性抑製預處理%心肌保護%心室肌細胞
납/개교환체%대사성억제예처리%심기보호%심실기세포
sodium/calcium exchanger%metabolic inhibition preconditioning%cardioprotection%ventricular myocyte
目的研究大鼠心室肌细胞在代谢性抑制预处理中钠/钙交换体(NCX)反向转运的活性,以及NCX反向转运抑制剂是否可以阻止代谢性抑制预处理后的心肌保护作用.方法酶解法分离制备钙耐受心肌细胞,用Fura-2/AM负载,采用双激发荧光光电倍增系统(IonOptix Photometry System)检测钙信号,用单心肌细胞动缘探测技术观察心肌细胞收缩/舒张功能,台盼蓝染色法检测细胞存活率.结果在代谢性抑制预处理30 min时,NCX反向转运被激活.NCX反向转运抑制剂KB-R 7943(0.5 μmol/L)可以抑制代谢性抑制预处理对心肌细胞收缩功能和细胞存活率的作用.NCX激动剂FA031(1 μmol/L)可以模拟代谢性抑制预处理后对心肌细胞收缩功能的保护作用,这一作用也可被KB-R 7943阻断.结论代谢性抑制预处理中,NCX反向转运的激活触发了代谢性抑制预处理后的心肌保护作用;NCX的抑制剂可以阻止代谢性抑制预处理后的心肌保护作用.
目的研究大鼠心室肌細胞在代謝性抑製預處理中鈉/鈣交換體(NCX)反嚮轉運的活性,以及NCX反嚮轉運抑製劑是否可以阻止代謝性抑製預處理後的心肌保護作用.方法酶解法分離製備鈣耐受心肌細胞,用Fura-2/AM負載,採用雙激髮熒光光電倍增繫統(IonOptix Photometry System)檢測鈣信號,用單心肌細胞動緣探測技術觀察心肌細胞收縮/舒張功能,檯盼藍染色法檢測細胞存活率.結果在代謝性抑製預處理30 min時,NCX反嚮轉運被激活.NCX反嚮轉運抑製劑KB-R 7943(0.5 μmol/L)可以抑製代謝性抑製預處理對心肌細胞收縮功能和細胞存活率的作用.NCX激動劑FA031(1 μmol/L)可以模擬代謝性抑製預處理後對心肌細胞收縮功能的保護作用,這一作用也可被KB-R 7943阻斷.結論代謝性抑製預處理中,NCX反嚮轉運的激活觸髮瞭代謝性抑製預處理後的心肌保護作用;NCX的抑製劑可以阻止代謝性抑製預處理後的心肌保護作用.
목적연구대서심실기세포재대사성억제예처리중납/개교환체(NCX)반향전운적활성,이급NCX반향전운억제제시부가이조지대사성억제예처리후적심기보호작용.방법매해법분리제비개내수심기세포,용Fura-2/AM부재,채용쌍격발형광광전배증계통(IonOptix Photometry System)검측개신호,용단심기세포동연탐측기술관찰심기세포수축/서장공능,태반람염색법검측세포존활솔.결과재대사성억제예처리30 min시,NCX반향전운피격활.NCX반향전운억제제KB-R 7943(0.5 μmol/L)가이억제대사성억제예처리대심기세포수축공능화세포존활솔적작용.NCX격동제FA031(1 μmol/L)가이모의대사성억제예처리후대심기세포수축공능적보호작용,저일작용야가피KB-R 7943조단.결론대사성억제예처리중,NCX반향전운적격활촉발료대사성억제예처리후적심기보호작용;NCX적억제제가이조지대사성억제예처리후적심기보호작용.
AIM To study the activity of reverse-mode Na +/Ca2+ exchanger (NCX) during metabolic inhibition pretreatment (MIP) of rat ventricular myocytes, and to determine whether the cardioprotection of metabolic inhibition preconditioning can be prevented by reverse-mode NCX inhibitor. METHODS Single ventricular myocytes were enzymatically isolated and loaded with Fura-2/AM. Intracellular calcium concentration ( [ Ca2 + ] i ) was measured by IonOptix Photometry System. The activity of reverse-mode NCX was assessed by withdrawal extracellular Na + and the changes of [ Ca2 + ] iwere measured. The amplitude of single myocyte contraction and cell viability were used as indices of cell injury and death, respectively. RESULTS MIP for 30 min significantly increased the activity of reverse-mode NCX. The effects of MIP on the amplitude of single surviving myocyte contraction and cell viability were attenuated by 0. 5 μmol/L KB-R 7943 (KBR) ,a specific inhibitor of reverse-mode NCX, administered before and during MIP. Pretreatment of cells with 1 μmol/L FA031 , a selective reverse-mode NCX enhancer, mimicked the effects of metabolic inhibition preconditioning on cell contraction, which was also blocked by 0. 5 μmol/L KBR. CONCLUSION During MIP the activation of reverse-mode NCX triggers the cardioprotection of metabolic inhibition preconditioning, which can be prevented by blocking NCX reverse-mode.